[1] Ghouri YA,Mian I,Rowe JH.Review of hepatocellular carcinoma:Epidemiology,etiology,and carcinogenesis. J Carcinog,2017,16(1):1-7.
[2] Poon RT,Fan ST.Hepatectomy for hepatocellular carcinoma:patient selection and postoperative outcome. Liver Transpl,2004,10(2):39-45.
[3] 钟南保,吕光明,陈忠华,等. 原发性巨大肝癌与小肝癌立体定向放射治疗计划比较. 实用肝脏病杂志,2011,14(4):283-285.
[4] Yang LY,Fang F,Ou DP,et al.Solitary large hepatocellular carcinoma:a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg,2009,249(1):118-123.
[5] Liver EAFTSOT.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma. J Hepatol,2012,56(4):908-943.
[6] Li N,Feng S,Xue J,et al.Hepatocellular carcinoma with main portal vein tumor thrombus:a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy. HPB (Oxford),2016,18(6):549-556.
[7] Zhou L,Rui JA,Zhou WX,et al.Edmondson-Steiner grade:A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract,2017,213(7):824-830.
[8] 张杰,段伯焕,朱功兵. HCC患者外科手术根治术后生存分析. 实用肝脏病杂志,2017,20(1):93-96.
[9] Shen JY,Li C,Wen TF,et al.A simple prognostic score system predicts the prognosis of solitary large hepatocellular carcinoma following hepatectomy. Medicine,2016,95(31):e4296.
[10] Jin YJ,Lee JW.Therapeutic priorities for solitary large:hepatocellular carcinoma in a hepatitis B virus endemic area:an analysis of a nationwide cancer registry database. J Surg Oncol,2017,115(4):407-416.
[11] Zhu SL,Ke Y,Peng YC,et al.Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization:a propensity score analysis. Plos One,2014,9(12):e115834.
[12] Chen WN,Chen JY,Jiao BY,et al.Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion. J Virol,2012,86(24):13533-13541.
[13] Yang P,Lin QJ,Feng Y,et al.TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell,2012,22(3):291-303.
[14] 白石磊,项红军,夏勇,等. 乙型肝炎病毒相关孤立性大肝癌手术切除的远期疗效及预后因素分析. 中华消化外科杂志,2017,16(2):151-158.
[15] Kim JM,Hwang IH,Jang IS,et al.Houttuynia cordata thunb promotes activation of HIF-1A-FOXO3 and MEF2A pathways to induce apoptosis in human HepG2 hepatocellular carcinoma cells. Integr Cancer Ther,2017,16(3):360-372.
[16] Yuan G,Zeng CL,Zhu DD,et al.Influences of RFA combined with TACE on the HIF-1α and EGR level of patients with primary hepatic carcinoma. Eur Rev Med Pharmacol Sci,201721(8):1738-1745.
[17] Liao CG,Kong LM,Zhou P,et al.miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation,migration and invasion through RhoC,uPAR and MMPs. J Transl Med,2015,12(1):234.
[18] Grigorie R,Alexandrescu S,Smira G,et al.Curative intent treatment of hepatocellular carcinoma-844 cases treated in a general surgery and liver transplantation center. Chirurgia,2017,112(3):289-300.
[19] Ramalho M,Matos AP,Alobaidy M,et al.Magnetic resonance imaging of the cirrhotic liver:diagnosis of hepatocellular carcinoma and evaluation of response to treatment-Part2. Radiol Bras,2017,50(1):38-47.
[20] Kudo M,Hatano E,Ohkawa S,et al.Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma:Japanese subgroup analysis of the REACH trial. J Gastroenterol,2017,52(4):1-10. |